Skip to main content

Research Repository

Advanced Search

Biomedical engineering approaches to enhance therapeutic delivery for malignant glioma

McCrorie, Phoebe; Vasey, Catherine E.; Smith, Stuart J.; Marlow, Maria; Alexander, Cameron; Rahman, Ruman

Biomedical engineering approaches to enhance therapeutic delivery for malignant glioma Thumbnail


Authors

Catherine E. Vasey

STUART SMITH stuart.smith@nottingham.ac.uk
Clinical Associate Professor



Abstract

© 2020 We review the challenges of next-generation therapeutics for both systemic and localised delivery to brain tumours and discuss how recent engineering advances may be used to enhance brain penetration of systemic delivery therapies. The unmet clinical need which drug delivery seeks to address is discussed with reference to the therapy obstacles that the intra-tumour heterogeneity of glioma present. The unmet chemistry and biomedical engineering challenge to develop controlled release therapeutics is appraised, with commentary on current success/failures in systemic carrier-mediated delivery, including receptor-targeted, cell-based, blood-brain-barrier disrupting and MRI-guided focused ultrasound. Localised therapeutic delivery is a relatively under-studied research avenue and is discussed with reference to existing technologies in preclinical development. These include convection-enhanced delivery, alternative catheter delivery, and neuro-surgically applied delivery systems such as polymeric hydrogels and interstitial spray. A myriad of nano-scale therapeutic delivery systems is emerging as potential future medicines for malignant brain tumours. Such biomedically-engineered systems will increasingly feature in next-generation neuro-oncological clinical trials to deliver repurposed and experimental therapeutics, aimed at achieving therapeutic drug concentrations in the brain, with associated mortality and morbidity benefits for patients.

Citation

McCrorie, P., Vasey, C. E., Smith, S. J., Marlow, M., Alexander, C., & Rahman, R. (2020). Biomedical engineering approaches to enhance therapeutic delivery for malignant glioma. Journal of Controlled Release, 328, 917-931. https://doi.org/10.1016/j.jconrel.2020.11.022

Journal Article Type Article
Acceptance Date Nov 11, 2020
Online Publication Date Nov 13, 2020
Publication Date Dec 10, 2020
Deposit Date Nov 23, 2020
Publicly Available Date Nov 23, 2020
Journal Journal of Controlled Release
Print ISSN 0168-3659
Electronic ISSN 1873-4995
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 328
Pages 917-931
DOI https://doi.org/10.1016/j.jconrel.2020.11.022
Keywords Pharmaceutical Science
Public URL https://nottingham-repository.worktribe.com/output/5047461
Publisher URL https://www.sciencedirect.com/science/article/pii/S0168365920306714?dgcid=rss_sd_all

Files




You might also like



Downloadable Citations